INS and metabolic syndrome: The excessive accumulation of intrahepatic triglycerides gradually attenuates the ability of insulin to suppress hepatic gluconeogenesis and triglyceride synthesis, resulting in the development of hyperglycemia, hyperinsulinemia and dyslipidemia [40].